Johnson & Johnson (JNJ) 100.60 $JNJ Final Glance:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Johnson & Johnson (JNJ) 100.60 $JNJ

Final Glance: Pharmaceuticals companies
AP - 1 hr 10 mins ago
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
JNJ: 100.60 (-0.95), BAX: 68.50 (-0.26), PFE: 34.79 (-0.21), BMY: 64.50 (-1.26)

Final Glance: Medical Devices companies
AP - 1 hr 10 mins ago
NEW YORK (AP) — Shares of some top medical devices companies were down at the close of trading:
ZMH: 117.52 (-1.05), JNJ: 100.60 (-0.95), BAX: 68.50 (-0.26)

AmerisourceBergen: A Great Growth Story
Bill Gunderson - Seeking Alpha - 2 hrs 25 mins ago
AmerisourceBergen (NYSE: ABC ) is a distributor of drugs and health supplies based in Chesterbrook, Pennsylvania. It runs 26 U.S. pharmaceutical distribution centers, 4 U.S. specialty distribution centers, and 2 Canadian distribution hubs, in order...
ABC: 113.67 (+0.18), JNJ: 100.60 (-0.95), WBA: 84.68 (-1.31), MCK: 226.20 (-2.94), MWIV: 190.00 (+0.10), GILD: 98.13 (-2.56), CAH: 90.27 (-0.53), ABBV: 58.54 (+0.30)

How Much Money Will You Need To Retire?
Dividends4Life - Seeking Alpha - 2 hrs 47 mins ago
How much money will you need before retiring ? This obviously is a very important question, but also a very difficult question to answer. There are many factors and assumptions that go into estimating the income that will be needed in retirement....
MMM: 164.95 (-1.10), JNJ: 100.60 (-0.95), ABT: 46.33 (-0.75), GPC: 93.19 (-0.67), CTBI: 33.16 (-0.31), CB: 101.10 (-0.74), AFL: 64.01 (-0.19)

Setting Up And Running Your Dividend Growth Investment Plan Like A Business
On2Freedom - at Seeking Alpha - Tue Mar 31, 2:27PM CDT

KO: 40.55 (+0.04), JNJ: 100.60 (-0.95), BAX: 68.50 (-0.26), AZN: 68.43 (-1.51), VIG: 80.47 (-0.77), VWO: 40.87 (-0.03), PG: 81.94 (-0.78), PEP: 95.62 (-0.90)

Midday Glance: Medical Devices companies
AP - Tue Mar 31, 1:48PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are down at 1 p.m.:
ZMH: 117.52 (-1.05), JNJ: 100.60 (-0.95), BAX: 68.50 (-0.26)

Midday Glance: Pharmaceuticals companies
AP - Tue Mar 31, 1:48PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
JNJ: 100.60 (-0.95), BAX: 68.50 (-0.26), PFE: 34.79 (-0.21), BMY: 64.50 (-1.26)

United Kingdom Baby Toiletries Market 2015-2019 with Johnson & Johnson, Kimberly-Clark & Procter & Gamble Dominating
PR Newswire Europe - Tue Mar 31, 12:42PM CDT
DUBLIN, Mar. 30, 2015 /PRNewswire/ --Research and Markets
JNJ: 100.60 (-0.95), PG: 81.94 (-0.78)

Global Crohn's Disease (CD) Market 2015-2019: Key Players are AbbVie, Astra Zeneca, Biogen Idec, Johnson & Johnson, Takeda Pharmaceutical & UCB
PR Newswire Europe - Tue Mar 31, 11:52AM CDT
DUBLIN, Mar. 30, 2015 /PRNewswire/ --Research and Markets
JNJ: 100.60 (-0.95), BIIB: 422.24 (-9.38)

Global Baby Oil Market 2015-2019 with Chicco USA, Johnson & Johnson & Pigeon Dominating
M2 - Tue Mar 31, 11:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qh7gx8/global_baby_oil) has announced the addition of the "Global Baby Oil Market 2015-2019" report to their offering. The Global Baby Oil market to grow at a CAGR of 7.36 percent over the period 2014-2019 Baby oil is used for massaging babies, which stimulates the production of the feel-good hormone oxytocin and helps in relaxing them. Baby oil is extensively used for massaging the body and hair of babies. This report covers the present scenario and the growth prospects of the Global Baby Oil market for the period 2015-2019. To calculate the market size, the report takes into account the revenue generated from sales of baby body massage oils and baby hair massage oils. Growing organized retail sector is one of the major trends being witnessed in the market. The Retail industry, especially in developing countries, is expected to grow rapidly following an increase in the numbers of organized retail outlets such as hypermarkets, supermarkets, and discount stores. According to the report, growing popularity of massage oils is propelling the growth of the market. Parents use a variety of baby care products to aid healthy development in their babies. Among the baby care practices, massaging has become a priority. Further, the report states that declining birth rates in developed countries, owing to the great recession and high unemployment rate, hinders market growth. Major vendors are trying to develop efficient baby care products with natural eco-friendly materials to improve product sales. Key Vendors - Chicco USA - Johnson & Johnson - Pigeon Other Prominent Vendors - Bio Veda Action Research - Dabur - Farlin - Himalaya Drug Company - Nateera International - Nestle - Sebapharma - Tollyjoy Baby Products Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Key Emerging Economies in Baby Care Market - Global Baby Oil Market - Global Baby Oil Market by Product Segmentation - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis - Other Prominent Vendors For more information visit http://www.researchandmarkets.com/research/qh...l_baby_oil
JNJ: 100.60 (-0.95)

Procter & Gamble Vs. Johnson & Johnson: A Regression Analysis Of Dividend Growth And Stock Price
Michael Grogan - at Seeking Alpha - Tue Mar 31, 9:34AM CDT

JNJ: 100.60 (-0.95), PG: 81.94 (-0.78)

Early Glance: Pharmaceuticals companies
AP - Tue Mar 31, 9:29AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
JNJ: 100.60 (-0.95), BAX: 68.50 (-0.26), PFE: 34.79 (-0.21), BMY: 64.50 (-1.26)

Early Glance: Medical Devices companies
AP - Tue Mar 31, 9:29AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are down at 10 a.m.:
ZMH: 117.52 (-1.05), JNJ: 100.60 (-0.95), BAX: 68.50 (-0.26)

The Zacks Analyst Blog Highlights: Google, Johnson & Johnson, AbbVie, Yahoo and Microsoft - Press Releases
Zacks Equity Research - Zacks Investment Research - Tue Mar 31, 8:30AM CDT
The Zacks Analyst Blog Highlights: Google, Johnson & Johnson, AbbVie, Yahoo and Microsoft
YHOO: 44.44 (-0.51), JNJ: 100.60 (-0.95), ABBV: 58.54 (+0.30), GOOGL: 554.70 (-6.44), MSFT: 40.65 (-0.31)

Johnson & Johnson Division Attempts Final Appeal in Effort to Overturn Multiple USPTO Decisions Issued in DECN's Favor
Marketwired - Tue Mar 31, 8:20AM CDT
Decision Diagnostics Corp. (OTC PINK: DECN), the manufacturer, quality plan administrator and the exclusive worldwide sales, service and regulatory processes agent for the popular GenStrip(TM) 50, the FDA cleared Green Glucose Test Strip, specifically designed to work with the market leading Johnson & Johnson's LifeScan OneTouch Ultra family of glucose testing meters, today announced that Lifescan/J&J has filed its final appeal in the United States Court of Appeals for the Federal Circuit (the patent appeals court), in an effort to overturn an IPR (USPTO court) decision by the U.S. Patent and Trademark Office that Pharma Tech proved that all of the claims in J&J/Lifescan's U.S. Patent 7,250,105, are unpatentable.
JNJ: 100.60 (-0.95)

Soft Tissue Repair Market Report - Global Forecast to 2019: Mesh/Tissue patch, Allograft, Xenograft, Suture Anchor, Interference Screws, Laparoscopic Instruments
M2 - Tue Mar 31, 8:06AM CDT
Research and Markets (http://www.researchandmarkets.com/research/h9bprv/soft_tissue) has announced the addition of the "Soft Tissue Repair Market by Product (Mesh/Tissue patch, Allograft, Xenograft, Suture Anchor, Interference Screws, Laparoscopic Instruments) by Application (Hernia, Dural, Orthopedic, Skin, Dental, Vaginal, Breast augmentation) - Global Forecast to 2019 " report to their offering. The global soft tissue repair market is expected to reach $14.7 billion in 2019 from $10.3 billion in 2014, at a CAGR of 7.5% during the forecast period of 2014 to 2019. Soft tissue repair products are used to repair and reconstruct soft tissue injuries. The soft tissue repair market is mainly driven by technological advancements, innovative product offerings, increasing incidence of soft tissue injuries among the aging population, increasing participation in sports, and the increasing obesity rate. However, the ambiguity in reimbursement for these products and the increasing cost of surgical procedures are expected to restrain the growth of this market in the forecast period. Market growth will be attributed to innovative new product launches, the rising demand for soft tissue repair treatment from the aging population, increasing healthcare expenditure, and the lack of substitutes. The soft tissue repair market studied in this report is mainly segmented by products and applications. The market, by products, is segmented into tissue patch/mesh, soft tissue fixation devices, and laparoscopic instruments. On the basis of application the market is segmented into hernia repair, dural repair, vaginal sling procedure, skin repair, orthopedic repair, dental repair, and breast reconstruction repair. Developed geographies like North America and Europe are saturated markets and expected to grow at a slower rate, whereas the Asian market is expected to witness the highest growth due to the increasing number of soft tissue repair surgical procedures (which is caused by the rising aging population and huge patient base). The key players operating in this market are LifeCell Corporation (U.S.), Organogenesis (U.S.), C.R. Bard, Inc. (U.S.), Johnson & Johnson (U.S.), Covidien plc (Ireland), Arthrex, Inc. (U.S.), Smith & Nephew plc (U.K.), Integra Lifesciences Corporation (U.S.), Wright Medical Technology (U.S.), and Stryker Corporation (U.S.). Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Industry Insights 6 Market Overview 7 Soft Tissue Repair Market, By Product 8 Soft Tissue Repair Market, By Application 9 Soft Tissue Repair Market, By Region 10 Competitive Landscape 11 Company Profiles - American Medical Systems Inc. - Arthrex, Inc. - C.R Bard, Inc. - Covidien PLC - Integra Lifesciences Corporation - Johnson & Johnson - Lifecell Corporation - Lifenet Health, Inc. - Smith & Nephew PLC - Wright Medical For more information visit http://www.researchandmarkets.com/research/h9...oft_tissue
SNN: 34.17 (-0.01), JNJ: 100.60 (-0.95), BCR: 167.35 (-2.02)

Renal Failure Global Clinical Trials Review, H1, 2015
M2 - Tue Mar 31, 3:42AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8frs3p/renal_failure) has announced the addition of the "Renal Failure Global Clinical Trials Review, H1, 2015" report to their offering. Renal Failure Global Clinical Trials Review, H1, 2015 includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Renal Failure. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Top Companies Participating in Renal Failure Therapeutics Clinical Trials - Sanofi - Amgen Inc. - F. Hoffmann-La Roche Ltd. - Novartis AG - AbbVie Inc. - Pfizer Inc. - AstraZeneca PLC - Shire Plc - Abbott Laboratories - Johnson & Johnson For more information visit http://www.researchandmarkets.com/research/8f...al_failure
JNJ: 100.60 (-0.95), ABT: 46.33 (-0.75), SHPG: 239.29 (-2.69), PFE: 34.79 (-0.21), AZN: 68.43 (-1.51), AMGN: 159.85 (-4.45), ABBV: 58.54 (+0.30), NVS: 98.61 (-2.70)

India Traditional Wound Management Market Outlook to 2020
M2 - Tue Mar 31, 3:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fgwdst/india_traditional) has announced the addition of the "India Traditional Wound Management Market Outlook to 2020" report to their offering. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Traditional Wound Management market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Scope - Market size data for Traditional Wound Management market segments - Gauzes, Sponges, Bandages, Abdominal Pads and Gauze Sponges. - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Traditional Wound Management market. - Global corporate-level profiles of key companies operating within the India Traditional Wound Management market. - Key players covered include Johnson & Johnson, Medline Industries, Inc. and Covidien plc. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Traditional Wound Management Market, India 4 Overview of Key Companies in India, Traditional Wound Management Market 5 Appendix Companies Mentioned - Johnson & Johnson - Covidien plc - BSN medical GmbH For more information visit http://www.researchandmarkets.com/research/fg...raditional
JNJ: 100.60 (-0.95)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 10

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 8

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 12

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 11

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 9

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 11

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 14

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 15

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Mercury Capital Secures $4.35M Loan for Retail Hub

Updated Category News Views 21

Mercury Capital Partners Banks on Retail Development They say the beauty's in the numbers, but the magic happens when you make those numbers work for you. Mercury Capital Partners (MCP) is wrangling dollars like no one's business, pushing a $4.35 million construction loan into the Fort Myers scene like it's a walk in the park. We're looking at Estero Oaks, a...

Continue Reading
Amazon Analysts Update Forecasts for Upcoming Earnings Report

Updated Category News Views 130

Amazon's Upcoming Earnings Call Amazon.com, Inc. (NASDAQ: AMZN) is set to unveil its earnings results for the second quarter. This announcement will provide valuable insights into the company's financial health and operational performance. Market expectations are leaning toward a positive outlook, as analysts predict robust earnings and revenue growth. Predicted Earnings...

Continue Reading
Understanding the Recent Surge in ServiceNow Options Activity

Updated Category News Views 82

Understanding the Recent Surge in ServiceNow Options Activity Recently, a notable shift occurred in the options market surrounding ServiceNow (NYSE: NOW), drawing attention from both institutional and retail investors. With deep pockets behind these moves, it's crucial to analyze what it could mean for the future of the stock. It’s always intriguing when a significant...

Continue Reading
Join the Exciting Bybit Boost Battle for Weekly USDT Prizes!

Updated Category News Views 176

Join the Exciting Bybit Boost Battle for Weekly USDT Prizes! Bybit, recognized as the second-largest cryptocurrency exchange globally by trading volume, has initiated a vibrant competition called the Boost Battle. This thrilling event allows traders to participate weekly, showcasing their skills and strategies. The grand prize rolls out weekly, presenting winners with the...

Continue Reading
Desert Control's Q2 Progress: Innovations and Financial Insights

Updated Category News Views 190

Desert Control's Q2 2025 Report Summary Desert Control AS (DSRT) has made commendable strides in the second quarter of 2025, revealing significant operational achievements and promising financial results. This report encapsulates the journey and progress of the company, focusing on their innovative solutions that enhance soil health and water conservation. Operational...

Continue Reading